Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized EpilepsyEmanuele Cerulli Irelli, Biagio Orlando, Chiara Pizzanelli et al.|JAMA Neurology|2023Cited by 29
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)Simona Lattanzi, Roberta Ciuffini, Laura Canafoglia et al.|Drugs & Aging|2022Cited by 21
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World StudySimona Lattanzi, Roberta Ciuffini, Laura Canafoglia et al.|Neurology and Therapy|2022Cited by 16
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)Simona Lattanzi, Domenico Ciampanelli, Laura Canafoglia et al.|CNS Drugs|2021Cited by 4
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk StudySimona Lattanzi, Roberta Ciuffini, Laura Canafoglia et al.|Neurology and Therapy|2025Cited by 2